波多野结衣办公室双飞_制服 丝袜 综合 日韩 欧美_网站永久看片免费_欧美一级片在线免费观看_免费视频91蜜桃_精产国品一区二区三区_97超碰免费在线观看_欧美做受喷浆在线观看_国产熟妇搡bbbb搡bbbb_麻豆精品国产传媒

USEUROPEAFRICAASIA 中文雙語Fran?ais
Business
Home / Business / Q and A with CEO

Serving in the name of progress

By Zhong Nan | China Daily | Updated: 2017-09-08 07:29

Serving in the name of progress

Joaquin Duato, executive vice-president and worldwide chairman of pharmaceuticals at Johnson & Johnson. [Photo provided to China Daily]

A senior executive at Johnson & Johnson talks about the group's strategy in China and the rest of the world

Joaquin Duato had dreams of playing tennis for Spain as a child.

At 55, he is now the executive vice-president and worldwide chairman of pharmaceuticals at blue chip brand Johnson& Johnson.

"I'm an avid tennis player and as a child I used to dream of one day representing Spain," he said during a visit to Beijing.

Instead he has represented the global healthcare giant for the past 28 years and helped shape the multinational's strategy in China and across the world.

"The healthcare and pharmaceutical industries have developed notably in China during the past three decades," Duato said. "Pharmaceutical companies are getting medicines to patients faster than they were before."

Moves by the China Food and Drug Administration to streamline the approval of new medicines have opened up the industry along with updating the National Reimbursement Drug List.

Last month, the Johnson & Johnson subsidiary, Xi'an Janssen Pharmaceutical Ltd, was granted approval from the CFDA for its Imbruvica capsules, which are used to treat adult patients with chronic lymphocytic leukemia and mantle cell lymphoma.

"These factors have improved the situation in China for innovation-based pharmaceutical companies," Duato added.

With more than 125,000 staff in nearly 60 countries and regions, Johnson & Johnson sells its products, such as consumer and healthcare, pharmaceuticals and medical devices, in about 200 nations and regions.

Naturally, China has become "vitally" important to the United States-based group.

In an interview with China Daily, Duato talked about the company's vision, its strategy in China, and his love of tennis and giant pandas.

What are Johnson & Johnson's plans in China during the next five years?

China is vitally important to us globally and we remain committed to investing in China, and making a significant contribution to the country's economic growth.

Since establishing operations here in 1985, we have expanded our presence significantly and today employ more than 2,500 people in our Beijing headquarters, our state-of-the-art manufacturing site in Xi'an, and our research and development operations. These include the groundbreaking R&D center in Shanghai and the Johnson & Johnson Innovation Center.

Following an investment of $290 million, our new supply chain hub for innovation in Asia is scheduled to open in Xi'an (in Shaanxi province) in 2019. The objective is to serve the rapidly expanding needs of China and other markets in the region. The plant is expected to set a new standard in pharmaceutical manufacturing here.

At full capacity, the plant is expected to produce 400 million tablets, capsules, creams, suppositories and powders a year.

What are your priorities in the country?

Globally, and in China, our strategy is to focus on discovering and developing transformational medical innovations for patients in six high priority disease areas, which address major unmet (unfulfilled) treatment needs.

These include oncology, immunology, neuroscience, infectious diseases, cardiovascular and pulmonary hypertension.

We will (also) continue to support China's aspiration to become a leading global pharmaceutical innovator through forward-looking investments. This will enable the discovery of game-changing therapies which address unmet medical needs.

What business opportunities will emerge through the Belt and Road Initiative?

Xi'an Janssen was, and will continue to be, a forerunner in establishing joint ventures with local partners in China. We established our operations in Shaanxi province in 1985, a critical area of the Belt and Road Initiative.

We also attribute these joint-venture partnerships and our continued investment in Xi'an as critical factors to our success in China. We will continue this model (in the future).

What is your biggest achievement here?

I am proud of guiding the business toward a greater focus on transformational medical innovations for patients.

Zytiga, a new kind of treatment for men with (a type of) prostate cancer, is a great example of cutting-edge science and true medical innovation that significantly prolongs lives.

How will you compete with competitors across the world and in China?

In 2011, we made the decision to focus our business on identifying and bringing transformational medical innovation. We are an innovation-based company which globally spends 50 percent more in research and development than in sales and marketing.

With a growing core business of medicines and a strong lineup of innovative products expected to launch or file during the next five years, we are leading the industry in advancing the health of patients around the world.

With our proven global commercial capabilities, we are well-positioned to continue delivering strong, long-term, sustainable growth.

How does digital technology affect your business?

Digital technology is important in discovery and development because we use information technology to screen targets and to model our clinical trial designs.

It is critical in manufacturing as we use machine learning and artificial intelligence, or AI, to identify areas in which we can eliminate waste and establish better quality control measures.

We now have access to vast amounts of data about how our medicines are used by physicians and patients once they are on the market. So this helps us better understand the risk-benefit ratio.

What makes an effective leader of a major multinational company?

I am proud to have worked at Johnson & Johnson for more than 28 years. I have had a varied career in different sectors of the healthcare industry, and in different countries and regions around the world. This has helped me continue to evolve and adapt my leadership style.

For the first half of my career, I was based in Europe and I was successful by using a direct, straight forward leadership style. But after moving to the United States I had to re-evaluate my style and learn to navigate cultural differences.

I would say my key leadership approach is adaptability-being able to draw upon what best suits the situation and the team I am leading.

How has your style changed over time?

Different business challenges need different leadership styles. When I became the head of our North American operation, I had to work quickly and alone to guide the business through a challenging turnaround.

But once it had stabilized, I had to open up to a more inclusive and consultative leadership style as we developed a long-term strategy for growth.

How do you handle setbacks?

I view setbacks as opportunities to grow, both as an individual and as a business. The challenges and hardships our group faced during the 2007 recession can almost be seen as a necessary step in achieving the remarkable success we have today.

The setbacks we faced forced us to make our organization a leaner and more focused operation. Our extremely successful model of embracing innovation was born.

So now, whenever I am faced with a setback, I always look for an opportunity that might arise.

What are your hobbies?

My role involves a lot of travel, so whenever I am at home my first priority is spending time with my family. I love being with my wife, son and daughter.

This summer, I have spent a number of days traveling with my family to visit potential colleges that my daughter might attend next year.

I am also an avid tennis player and as a child I used to dream of one day representing Spain.

How do you spend your free time in China?

Usually, I am focused on meetings with customers and government officials. But I understand that through our collaboration with Shaanxi Rare Wild Animals Rescue and Research Center, which aims to further protect the giant panda in China, we had the honor of naming a baby panda "Johnson& Johnson". If I have free time, I am hoping to visit him.

CV

Age: 55

Nationality: Spanish and American

Career:

2017 onwards: Chairman of the Board, PhRMA

2011 onwards: Worldwide Chairman, Pharmaceuticals, Johnson& Johnson

2009-11: Company Group Chairman, Americas, The Janssen Pharmaceutical Companies of Johnson& Johnson

2007-09: Company Group Chairman, Diagnostics, Johnson & Johnson

2005-07: President, Ortho Biotech Products LP, Johnson& Johnson

Education: Undergraduate degree in Economics and Business

MBA from ESADE, Barcelona

Masters of International Management from Thunderbird, Phoenix, US.

Family: Married with a son and a daughter

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
波多野结衣办公室双飞_制服 丝袜 综合 日韩 欧美_网站永久看片免费_欧美一级片在线免费观看_免费视频91蜜桃_精产国品一区二区三区_97超碰免费在线观看_欧美做受喷浆在线观看_国产熟妇搡bbbb搡bbbb_麻豆精品国产传媒
在线观看视频一区二区欧美日韩| 亚洲午夜电影网| 国产精品中文字幕日韩精品 | 亚洲一区二区三区爽爽爽爽爽| 成人18精品视频| 91成人福利视频| 1区2区3区欧美| 99re在线视频这里只有精品| 一本大道av一区二区在线播放| 综合久久久久久久| 91一区二区在线观看| 在线观看免费成人| 亚洲综合色自拍一区| 国产xxx在线观看| 7777精品伊人久久久大香线蕉超级流畅| 亚洲国产中文字幕| 国产美女视频免费观看下载软件| 欧美一区二区三区在线电影| 麻豆精品新av中文字幕| 欧美福利第一页| 国产精品亲子伦对白| 99精品国产热久久91蜜凸| 欧美婷婷六月丁香综合色| 亚洲成人av免费| 熟女俱乐部一区二区视频在线| 精品播放一区二区| 国产成人精品影视| 欧美亚日韩国产aⅴ精品中极品| 亚洲动漫第一页| 波多野结衣av在线免费观看| 久久久亚洲午夜电影| 成人黄色小视频在线观看| 欧美性生活久久| 秋霞成人午夜伦在线观看| 一级黄色片网址| 国产精品久久久久影院亚瑟| 欧美色图校园春色| 日韩欧美国产三级电影视频| 国产酒店精品激情| 在线视频一区二区三| 婷婷久久综合九色综合绿巨人| 亚洲av综合一区二区| 中文字幕不卡在线| 少妇极品熟妇人妻无码| 欧美成人猛片aaaaaaa| 国产成人精品亚洲日本在线桃色| 欧美综合视频在线观看| 奇米色一区二区三区四区| 国产精品18在线| 亚洲一区二区三区中文字幕 | 在线免费看黄色片| 久久嫩草精品久久久精品一| 不卡电影免费在线播放一区| 91精品国产乱码| 国产成人精品aa毛片| 欧美精品在线观看一区二区| 精品一区精品二区高清| 在线看日本不卡| 久久精品国产精品亚洲精品| 一本大道综合伊人精品热热| 日本不卡在线视频| 色综合亚洲欧洲| 蜜乳av一区二区| 色哟哟欧美精品| 美女性感视频久久| 91黄色免费网站| 韩国在线一区二区| 欧美日韩激情一区| 国产成a人亚洲精品| 91精品国产综合久久国产大片| 国产盗摄精品一区二区三区在线| 欧美日本国产一区| 国产jizzjizz一区二区| 日韩欧美资源站| 91色综合久久久久婷婷| 国产亚洲一区二区三区在线观看 | 91网页版在线| 久久天天做天天爱综合色| 亚洲欧洲国产视频| 国产精品久久久久影院| 成人免费无遮挡无码黄漫视频| 亚洲精选免费视频| 免费精品在线视频| 美女视频网站久久| 欧美日韩成人在线一区| 成人成人成人在线视频| 久久老女人爱爱| 熟妇高潮精品一区二区三区| 一区二区在线免费| 午夜国产福利视频| 麻豆免费精品视频| 91精品视频网| 欧美午夜精品一区二区| ...xxx性欧美| 北条麻妃在线观看视频| 久久精品国产精品青草| 欧美一区二区三区在线观看视频| 97久久精品人人澡人人爽| 中文字幕巨乱亚洲| 亚洲最大成人综合网| 热久久一区二区| 欧美久久久久久久久中文字幕| 成人精品高清在线| 国产欧美精品一区二区三区四区| 醉酒壮男gay强迫野外xx| 亚洲chinese男男1069| 欧美午夜在线观看| 91麻豆精品视频| 亚洲免费在线看| 国产av无码专区亚洲av毛网站| 国产一区二区三区四区五区美女 | 午夜黄色福利视频| 老鸭窝一区二区久久精品| 欧美一区二区三区日韩| 国产一线在线观看| 午夜视频久久久久久| 欧美精品视频www在线观看 | 久久久久亚洲av片无码v| 亚洲色图制服诱惑| 91porn在线视频| 不卡一区二区三区四区| 亚洲欧洲日韩女同| 色综合 综合色| 97精品国产97久久久久久久久久久久| 中文在线一区二区| 欧美日韩午夜视频| proumb性欧美在线观看| 亚洲色图色小说| 欧美亚洲综合色| 又色又爽又黄18网站| 亚洲成人你懂的| 日韩一区国产二区欧美三区| 国产三级视频网站| 久久精品国产亚洲aⅴ| 久久免费电影网| 精品国产大片大片大片| 成人动漫一区二区三区| 亚洲乱码中文字幕| 欧美日韩大陆一区二区| 亚洲精品中文字幕在线播放| 美女一区二区三区在线观看| 久久综合国产精品| 91视频青青草| 91在线免费播放| 五月天激情综合| 欧美精品一区二区三区在线播放| 日韩黄色中文字幕| a美女胸又www黄视频久久| 一区二区高清在线| 91精品久久久久久蜜臀| 免费网站在线高清观看| 国产91精品露脸国语对白| 亚洲精品综合在线| 欧美一二三区在线| 久久精品日韩无码| 精品人妻一区二区三| 日本亚洲一区二区| 国产亲近乱来精品视频| 日本丶国产丶欧美色综合| 69亚洲乱人伦| 韩国女主播成人在线| 亚洲天堂免费在线观看视频| 欧美日韩国产三级| 影音先锋制服丝袜| 97久久精品人人澡人人爽| 日韩中文字幕麻豆| 欧美国产一区在线| 欧美吻胸吃奶大尺度电影| a级大片在线观看| 成人app在线观看| 舔着乳尖日韩一区| 日本一区二区三区国色天香 | 岛国精品一区二区| 亚洲福利一区二区| 国产婷婷一区二区| 欧美午夜视频网站| 老头老太做爰xxx视频| 91视频.com| 激情综合网av| 一区二区三区四区在线免费观看| 精品少妇一区二区三区在线播放| 欧美丰满熟妇bbbbbb| 最近中文字幕无免费| 风间由美一区二区av101| 偷窥国产亚洲免费视频| 国产精品网站导航| 日韩一区二区免费在线电影| 澳门黄色一级片| 免费看污片的网站| 亚洲欧美激情一区二区三区| 国产在线麻豆精品观看| 亚洲国产三级在线| 中文字幕av一区 二区| 日韩欧美中文字幕一区| 日本久久一区二区| 欧美午夜激情影院| 国产一级黄色录像| 99久久99精品久久久久久| 极品美女销魂一区二区三区 | 精品理论电影在线|